Glenmark Life Sciences Limited IPO

Glenmark Life Sciences Limited is listed in the MAINBOARD segment with a price band of ₹695 to ₹720. The figures below are as reported by the exchanges and public sources.

Glenmark Life Sciences Limited IPO — key facts

• The Glenmark Life Sciences Limited IPO price band is ₹695 to ₹720 per share.
• As of 5 September 2026, the Glenmark Life Sciences Limited IPO subscription status is 44.17x overall.
• The issue is open from 27-JUL-2021 to 29-JUL-2021.
• Glenmark Life Sciences Limited listed on 06-AUG-2021.
• Glenmark Life Sciences Limited listed at ₹748.2. The listing gain was 3.9% against the upper end of the issue price band.

Glenmark Life Sciences Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price band

₹695 – ₹720

Issue size

₹1513.6 Cr

Fresh issue

₹1060 Cr

Offer for sale

₹453.6 Cr

Opens

27-JUL-2021

Closes

29-JUL-2021

Listing

06-AUG-2021

Total subscription

44.17x

Retail

14.63x

QIB

36.97x

NII

122.54x

Lead managers

BOFA Securities (left lead)

Listing price

₹748.2

Listing day change

+3.9%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.